Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose ...

Nuvaxovid is supplied in a single-dose prefilled syringe containing 0.5mL suspension for intramuscular injection; it should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F).

Novavax (NASDAQ:NVAX) got good news Wednesday morning. Swissmedic, the Swiss Agency for Therapeutic Products, gave Nuvaxovid, the company’s protein-based Covid-19 vaccine, conditional marketing ...

GAITHERSBURG, Md., Jan. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious ...

Nuvaxovid includes an engineered fragment of the spike protein itself—albeit one without the genetic material that causes actual disease. It’s not a totally new approach to vaccine design.

Moderna MRNA announced that the FDA has approved its supplemental biologics license application seeking approval for COVID-19 vaccine, Spikevax, for use in children aged six months to 11 years, who ...

GAITHERSBURG, Md., Nov. 18, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious ...

GAITHERSBURG, Md., Dec. 7, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious ...

SINGAPORE — The Nuvaxovid Covid-19 vaccine by American firm Novavax has received the go-ahead from the Singapore authorities for use here in persons aged 18 and above. The first batch of the ...

STATEN ISLAND, N.Y. — The World Health Organization (WHO) issued an emergency use listing (EUL) for another coronavirus (COVID-19) vaccine — Nuvaxovid — it was announced Tuesday. The new ...

Novavax (NASDAQ:NVAX) got good news Wednesday morning. Swissmedic, the Swiss Agency for Therapeutic Products, gave Nuvaxovid, the company’s protein-based Covid-19 vaccine, conditional marketing ...